Join
Live feed
·
INSIDERFilingvia Quantisnow
Spero Therapeutics Inc. logo

SEC Form 4: Shukla Sath sold $7,748 worth of shares (6,017 units at $1.29), decreasing direct ownership by 1% to 572,500 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.